Vexev has raised $6 million in new funding to accelerate the path to FDA clearance and commercialization of its robotic ultrasound platform, VxWave. The funding comes after successful clinical study results showing high scanning success rates. VxWave aims to improve access to standardized vascular imaging, particularly for dialysis patients. This raise brings Vexev's total funding to $19 million.
Who to call at Vexev, and when
A new round usually means Vexev is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Vexev raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Vexev, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vexev. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Vexev
Location
Sydney, New South Wales, Australia
About
Vexev is an Australian medical robotics company that develops advanced vascular imaging technology designed to make high-quality scanning more accessible, consistent, and scalable. Built by experts in vascular fluid dynamics and computational imaging, Vexev's mission is to improve vascular care by building the next generation of imaging and intelligence tools for clinicians and healthcare providers. Its lead product, VxWave, focuses on upper limb vascular imaging, with an initial application in dialysis vascular access.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vexev raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SydneyBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics